Venlafaxine besylate compounds provide certain advantages over venlafaxine
hydrochloride and are useful in forming pharmaceutical compositions and n
treating venlafaxine-treatable diseases and conditions. Venlafaxine
besylate can be easily formulated into an extended release dosage form
including a hydrogel tablet as well as other matrix-based tablet
compositions. A preferred tablet making process involves hot melt
granulation.
